Key result
Genetic familial hypercholesterolemia affects ~10% of patients, with clinical criteria missing over a third of cases.
Cross-Sectional (n=103)
Answers are grounded in this paper and cite their sources.
Reveals that standard clinical diagnostic criteria frequently misclassify familial hypercholesterolemia in young acute coronary syndrome patients, highlighting the value of cascade genetic screening.
Aims: We sought to determine the prevalence of genetically confirmed familial hypercholesterolemia (FH) in patients with an acute coronary syndrome (ACS) and to compare the diagnostic performance of FH clinical criteria with FH genetic testing. Impact of FH genetic diagnosis at family level was also evaluated. Methods: Genetic study of seven genes associated with FH/increased LDL cholesterol (LDLR, APOB, PCSK9, APOE, STAP1, LDLRAP1,LIPA) was performed in 103 ACS patients, aged ≤65 years and with a LDL cholesterol >160 mg/dl (Figure). Dutch Lipid Clinic (DLC) and Simon Broome (SB) FH clinical criteria were applied. Familial genetic screening was performed in patients with pathogenic or possible pathogenic mutations. Results: Prevalence of genetically confirmed FH was 9.7% (95% CI: 5.36–16.96%; n=10). Prevalence of probable/definite FH according to the DLC criteria was 26.2% (95% CI: 18.26–35.96%; n=27). The SB criteria identified 27.2% (95% CI: 19.1–36.99%; n=28) patients with possible/definite FH. DLC and SB algorithms did not diagnose 4 (40%) and 3 (30%) of the genetically confirmed FH patients, respectively. 77.8% (95% CI: 57.27–90.63%; n=21) of patients diagnosed by the DLC algorithm and 75% (95% CI: 54.78–88.57%; n=21) by the SB criteria did not show any pathogenic FH mutation. Cascade genetic testing in first-degree relatives prompted the identification of 10 additional FH individuals. Seven of the family carriers had already high cholesterol, although only one of them was diagnosed of hypercholesterolemia and followed lipid-lowering treatment.
No takes yet. Share an insight, caveat, or question.
Amor‐Salamanca et al. (2017) conducted a cross-sectional in Acute coronary syndrome (n=103). FH clinical criteria (Dutch Lipid Clinic and Simon Broome algorithms) vs. FH genetic testing was evaluated on Prevalence of genetically confirmed familial hypercholesterolemia (95% CI 5.36-16.96). Genetically confirmed familial hypercholesterolemia had a prevalence of 9.7%, with clinical algorithms failing to diagnose 30-40% of confirmed cases.
Synapse has enriched 10 related papers. Consider them for comparative context: